Patent: 11,241,495
✉ Email this page to a colleague
Summary for Patent: 11,241,495
| Title: | Immunogenic composition |
| Abstract: | The present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa. |
| Inventor(s): | Ralph Leon Biemans, Dominique Boutriau, Carine Capiau, Philippe Denoel, Pierre Duvivier, Jan Poolman |
| Assignee: | GlaxoSmithKline Biologicals SA |
| Application Number: | US16/179,476 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,241,495
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Pfizer Ireland Pharmaceuticals Unlimited Company | PENBRAYA | meningococcal groups a, b, c, w, and y vaccine | Injection | 125770 | October 20, 2023 | 11,241,495 | 2038-11-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,241,495
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| African Regional IP Organization (ARIPO) | 2436 | ⤷ Start Trial |
| Argentina | 053935 | ⤷ Start Trial |
| Argentina | 056396 | ⤷ Start Trial |
| Argentina | 056397 | ⤷ Start Trial |
| Austria | E462444 | ⤷ Start Trial |
| Austria | E516816 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
